BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6547342)

  • 21. Pasta made from durum wheat semolina fermented with selected lactobacilli as a tool for a potential decrease of the gluten intolerance.
    di Cagno R; de Angelis M; Alfonsi G; de Vincenzi M; Silano M; Vincentini O; Gobbetti M
    J Agric Food Chem; 2005 Jun; 53(11):4393-402. PubMed ID: 15913301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A radioimmunoassay for wheat gliadin to assess the suitability of gluten free foods for patients with coeliac disease.
    Ciclitira PJ; Ellis HJ; Evans DJ; Lennox ES
    Clin Exp Immunol; 1985 Mar; 59(3):703-8. PubMed ID: 3987095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lectins in wheat gluten proteins.
    Concon JM; Newburg DS; Eades SN
    J Agric Food Chem; 1983; 31(5):939-41. PubMed ID: 6688815
    [No Abstract]   [Full Text] [Related]  

  • 24. A decapeptide from durum wheat prevents celiac peripheral blood lymphocytes from activation by gliadin peptides.
    Silano M; Di Benedetto R; Trecca A; Arrabito G; Leonardi F; De Vincenzi M
    Pediatr Res; 2007 Jan; 61(1):67-71. PubMed ID: 17211143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The specificity of wheat protein reactivity in coeliac disease.
    O'Farrelly C; Hekkens WT; Feighery C; Weir DG
    Scand J Gastroenterol; 1983 Jul; 18(5):603-7. PubMed ID: 6372068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cis-dichlorodiammine platinum(II) on the agglutinability of tumor and normal cells with concanavalin A and wheat germ agglutinin.
    Prasad SB; Sodhi A
    Chem Biol Interact; 1981 Sep; 36(3):355-67. PubMed ID: 6895188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical testing of bread made from nullisomic 6A wheats in coeliac patients.
    Ciclitira PJ; Hunter JO; Lennox ES
    Lancet; 1980 Aug; 2(8188):234-6. PubMed ID: 6105397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The shutdown of celiac disease-related gliadin epitopes in bread wheat by RNAi provides flours with increased stability and better tolerance to over-mixing.
    Gil-Humanes J; Pistón F; Barro F; Rosell CM
    PLoS One; 2014; 9(3):e91931. PubMed ID: 24633046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease.
    Rivabene R; Mancini E; De Vincenzi M
    Biochim Biophys Acta; 1999 Jan; 1453(1):152-60. PubMed ID: 9989255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic improvement of plant for coeliac disease.
    Pogna NE
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S154-9. PubMed ID: 12408461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental factors of celiac disease: cytotoxicity of hulled wheat species Triticum monococcum, T. turgidum ssp. dicoccum and T. aestivum ssp. spelta.
    Vincentini O; Maialetti F; Gazza L; Silano M; Dessi M; De Vincenzi M; Pogna NE
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1816-22. PubMed ID: 17914956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides.
    Auricchio S; De Ritis G; De Vincenzi M; Gentile V; Maiuri L; Mancini E; Porta R; Raia V
    Gastroenterology; 1990 Dec; 99(6):1668-74. PubMed ID: 2227281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new agglutinating activity from wheat flour inhibited by tryptophan.
    Minetti M; Aducci P; Teichner A
    Biochim Biophys Acta; 1976 Jul; 437(2):505-17. PubMed ID: 952930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of in vitro gamma-interferon production in coeliac disease as a response to gliadin peptides.
    Cornell HJ; Skerritt JH; Puy R; Javadpour M
    Biochim Biophys Acta; 1994 May; 1226(2):126-30. PubMed ID: 8204658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of immunogenicity of hydrolysed wheat flour in patients with coeliac disease after a short-term oral challenge.
    Mandile R; Picascia S; Parrella C; Camarca A; Gobbetti M; Greco L; Troncone R; Gianfrani C; Auricchio R
    Aliment Pharmacol Ther; 2017 Aug; 46(4):440-446. PubMed ID: 28627070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of extended amino acid motifs for focussing on toxic peptides in coeliac disease.
    McLachlan A; Cullis PG; Cornell HJ
    J Biochem Mol Biol Biophys; 2002 Oct; 6(5):319-24. PubMed ID: 12385967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes.
    van Herpen TW; Goryunova SV; van der Schoot J; Mitreva M; Salentijn E; Vorst O; Schenk MF; van Veelen PA; Koning F; van Soest LJ; Vosman B; Bosch D; Hamer RJ; Gilissen LJ; Smulders MJ
    BMC Genomics; 2006 Jan; 7():1. PubMed ID: 16403227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the gliadin-derived peptides which are biologically active in coeliac disease.
    Cornell H; Wieser H; Belitz HD
    Clin Chim Acta; 1992 Dec; 213(1-3):37-50. PubMed ID: 1477986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and partial chemical characterization of cell-surface glycopeptides from AS-30D rat hepatoma which possess binding sites for wheat germ agglutinin and concanavalin A.
    Smith DF; Neri G; Walborg EF
    Biochemistry; 1973 May; 12(11):2111-8. PubMed ID: 4350310
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction of natural and synthetic peptides derived from gliadin with different cell lines.
    Farré MA; Tlaskalová H; Nguyen HH; Kocna P; Tucková L; Krchnák V; Vetvicka V; Baudisová M; Pospisil M; Fric P
    Adv Exp Med Biol; 1995; 371B():1371-3. PubMed ID: 7502820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.